“…Participants ranged in breast cancer diagnosis from Stages 0 to III and from immediately post-treatment to as many as five years post-treatment. The majority of studies were conducted in the United States (n = 15) 2,7,9,19,31,34,39,42,44,45,47,52,54,55,58 and Europe (n = 13), 26,29,30,33,35,36,38,41,43,48,49,51,57 with the rest being conducted in Australia (n = 5), 8,40,46,50,53 Iran (n = 2), 32,37 and Korea (n = 1). 56 …”